Odimma Therapeutics

BiotechnologySeedStrasbourg, Franceodimma-therapeutics.com

Latest round

Seed

Last raised

Sep 2022

Total raised

$2.1M

Investors

1

About Odimma Therapeutics

Based in Strasbourg, France, and founded in 2017 by Jean-Marc Limacher, and Jessica Matta (CEO), Odimma Therapeutics operates as a biotechnology company specializing in personalized cancer immunotherapy and customized medicine. Odimma Therapeutics has developed an immunotherapy drug that aims to enhance personalized cancer immunotherapy. By utilizing a platform that combines three immune players, this drug can work in synergy with the immune system to induce and amplify an immune response. The firm empowers patients to effectively treat tumors with fewer side effects. In addition, the company's mission is to advance immunotherapy treatments and improve the lives of cancer patients.

Who invested in Odimma Therapeutics

1 investor across 3 rounds

See all investors in Odimma Therapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Sep 19, 2022

    Amount

    $0.9M

    Investors

    Locked

  2. Seed

    Oct 20, 2021

    Amount

    $0.6M

    Investors

    Locked

  3. Seed

    Jun 15, 2020

    Amount

    $0.6M

    Investors

    Locked

Questions about Odimma Therapeutics

Who invested in Odimma Therapeutics?

Odimma Therapeutics has 1 investor on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Odimma Therapeutics raised?

Odimma Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Odimma Therapeutics last raise money?

Odimma Therapeutics's most recent round on record is a Seed, in Sep 2022.

What does Odimma Therapeutics do?

Based in Strasbourg, France, and founded in 2017 by Jean-Marc Limacher, and Jessica Matta (CEO), Odimma Therapeutics operates as a biotechnology company specializing in personalized cancer immunotherapy and customized medicine.

Where is Odimma Therapeutics headquartered?

Odimma Therapeutics is headquartered in Strasbourg, France.

Which VCs invest in companies like Odimma Therapeutics?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Odimma Therapeutics's stage. Their profiles are linked below.

Raising like Odimma Therapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.